SOD1 and metabolic syndrome: The last of the trials was conducted to study the potential therapeutic effect of SOD-rich T. chuii in an animal model of metabolic syndrome, which is a cluster of metabolic disturbances such as abdominal obesity, hypertension, and hyperglycemia, and is characterized by low-grade chronic inflammation.